These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7951485)

  • 21. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperparathyroidism masked by osteomalacia. Is vitamin D administration in every case of osteomalacia problem-free?].
    Zuber M; Löliger M; Boner H; Haas HG
    Schweiz Med Wochenschr; 1986 May; 116(19):642-7. PubMed ID: 3715442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary hyperparathyroidism in a patient with Paget's bone disease].
    Guijarro de Armas MG; Pavón de Paz I; Zubieta Tabernero J; Civantos Modino S; Montaño Martínez JM; Díaz Guardiola P
    Endocrinol Nutr; 2010 Apr; 57(4):170-3. PubMed ID: 20381437
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
    Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
    Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease.
    Bergenfelz A; Valdemarsson S; Tibblin S
    Surgery; 1996 Jun; 119(6):624-33. PubMed ID: 8650602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive testing in the diagnosis of osteomalacia.
    Bingham CT; Fitzpatrick LA
    Am J Med; 1993 Nov; 95(5):519-23. PubMed ID: 7646591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery from metabolic bone disease in a girl with vitamin D deficiency rickets associated with primary hyperparathyroidism.
    Luboshitzky R; Hardoff R
    J Pediatr Endocrinol Metab; 1997; 10(2):237-41. PubMed ID: 9364360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV; Gupta N; Kochupillai N
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.
    Weinstein RS; Harris RL
    Calcif Tissue Int; 1990 Jun; 46(6):361-6. PubMed ID: 2114209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.
    Carty SE; Roberts MM; Virji MA; Haywood L; Yim JH
    Surgery; 2002 Dec; 132(6):1086-92; discussion 1092-3. PubMed ID: 12490859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers and imaging in non-malignant and malignant osteomalacia.
    Lüftner D; Bollow M; Stürzenbecher A; Kaufmann ; Priem F; Richter A; Gunther S; Geppert R; Petrides PE; Wernecke KD; Possinger K
    Int J Biol Markers; 2001; 16(2):136-41. PubMed ID: 11471897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive endoscopic-assisted parathyroidectomy for primary hyperparathyroidism.
    Lo CY; Chan WF; Luk JM
    Surg Endosc; 2003 Dec; 17(12):1932-6. PubMed ID: 14574548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
    Yonemura K; Suzuki H; Fujigaki Y; Hishida A
    Am J Med Sci; 2000 Nov; 320(5):334-6. PubMed ID: 11093687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary hyperparathyroidism presenting as slipped capital femoral epiphysis.
    Kumar G; Mathew V; Kandathil JC; Theruvil B
    Postgrad Med J; 2020 Apr; 96(1134):235-236. PubMed ID: 31615926
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
    Heylen A; Dasnoy D; Hustin J; Pochet JM
    Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia.
    Ueda M; Inaba M; Tahara H; Imanishi Y; Goto H; Nishizawa Y
    Intern Med; 2005 Apr; 44(4):307-10. PubMed ID: 15897641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.